Horizon 2020

Logo Horizon 2020

The I3A actively participates, leading and participating as partners, in European projects from the V Framework Program of the European Union (EU) and continues to work with enthusiasm to increase its participation in the current Horizon 2020 Framework Program, feeling especially proud to host three researchers funded by the European Research Council (ERC).

You can consult our lines of research to find the work areas in which the I3A can collaborate with your company or organization. We will be delighted to study the possibilities of joint participation in European projects.

Below are some of the Institute's H2020 projects, which cover participation in the 3 pillars of the program.

Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts

3D printing to restore a damaged heart
Logo H2020

"Heart On chip" based on induced pluripotent stem cell technology for personalized medicine

"Organs-on-a-chip" based on microfluidic technology represents a powerful tool for investigating rare disease mechanisms and testing new drugs and treatments due to its ability to mimic bespoke microenvironment architecture inspired by organ-level functions in vivo.
Logo European Comission

Predictive models and simulations in bone regeneration: a multiscale patient-specific approach

The goal of CURABONE is the development and combination of different technologies to achieve patient-specific treatments in the case of bone fractures
logo_UE

Accelerating Innovation in Microfabricated Medical Devices

The overall goal of Moore4Medical is to accelerate innovation in electronic medical devices.
Logo European Comission

Pilot-line for System in Tip Integration

The goal of POSITION-II is to bring innovation in the development and production of smart catheters by introducing open technology platforms for miniaturization, AD tip conversion, MEMS ultrasound devices and encapsulation.
Logo European Comission

PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers

PRIMAGE will address the study of two types of pediatric cancer that have a high mortality and therapeutic complexity: neuroblastoma and diffuse glioma of the brainstem.
logo_UE

Advanced and versatile PRInting platform for the next generation of active Microfluidic dEvices

PRIME will reduce the gap between microfluidics and non-specialized laboratories and end users, allowing the diffusion and penetration of the technology in various fields of application, as well as its geographical expansion to areas where large equipment is difficult to transport or resources they are scarce
Logo European Comission